Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2

CompletedOBSERVATIONAL
Enrollment

514

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Bradyarrhythmia
Trial Locations (39)

3600

Ziekenhuis Oost Limburg, Genk

Unknown

Hartcentrum Hasselt Jessa Ziekenhuis Campus Virga Jesse, Hasselt

Regionshospitalet Herning, Herning

Vejle Sygehus, Vejle

Viborg Sygehus, Viborg

CHRU Angers, Angers

CHRU de Clermont-Ferrand, Clermont-Ferrand

CHU Grenoble - Hopital Michallon, Grenoble

Hôpital la Roche sur Yon, La Roche-sur-Yon

Service de cardiologie, CHU Nancy-Brabois, Nancy

CHU de Nantes-Hopital Laennec, Nantes

Centre Hospitalier Général de Pau, Pau

CHU Poitiers - Hôpital La Miletrie, Poitiers

Herz- und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen

Universitätsklinikum, Leipzig

St.-Marien-Hospital GmbH, Lünen

Deutsches Herzzentrum München, München

Ospedale Cardinal Massaia, Asti

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari

Policlinico S. Orsola - Malpighi, Bologna

Pres. Osp. F. Ferrari, Casarano (LE)

Ospedale Civile San Leonardo, Castellammare di Stabia

Fondazione Toscana Gabriele Monasterio, Pisa

Ospedale Santa Maria degli Angeli, Pordenone

P.O. Santa Maria Delle Grazie, Pozzuoli

"Ospedale Misericordia e Dolce - AZIENDA USL 4 PRATO", Prato

Azienda ospedaliera Sant'Andrea, Rome

Policlinico Tor Vergata, Rome

Ziekenhuis Gelderse Vallei, Ede

Medisch Centrum Leeuwarden, Leeuwarden

St. Elisabeth Ziekenhuis, Tilburg

Gelre Ziekenhuis Zutphen, Zutphen

SUSCCH a.s., Banská Bystrica

The National Institute of Cardiovascular Diseases, Bratislava

Hospital Universitario Infanta Cristina, Badajoz

Hospital San Pedro, Logroño

Hospital de Torrejón, Torrejón

Blackpool Victoria, Blackpool

Barts Health NHS Trust, London

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY